|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/54 | |
| A61K 47/60 | |||
| A61K 38/12 | |||
| A61K 45/06 | |||
| C07K 14/47 |
| (11) | Number of the document | 3247405 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16701560.1 |
| Date of filing the European patent application | 2016-01-15 | |
| (97) | Date of publication of the European application | 2017-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/050206 |
| Date | 2016-01-15 |
| (87) | Number | WO 2016/116842 |
| Date | 2016-07-28 |
| (30) | Number | Date | Country code |
| 201562107040 P | 2015-01-23 | US |
| (72) |
KANTER, Aaron, US
USERA, Aimee Richardson, US
ZECRI, Frederic, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE |
| SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE |